License-in Demand for Repaglinide

Member of Farmavita.Net is looking for suppliers and EU CTD dossier for Repaglinide 0,5 mg, 1 mg and 2 mg.

License-in territory are countries of south-east Europe.

Demand is valid subject to confirmation, country by country. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights. Farmavita.Net is not owner of offered products/licenses and do not take any liability related to them. However, as the licensing agent we do our best to facilitate that closed licensing agreements are made on mutual benefit of contracting parties and without infringement of intellectual property of third parties. 

• Biotech in the New EU Member States (28/09/2009)
• Repaglinide (17/09/2009)
• Intellectual Properties Rights (21/07/2009)

• Citalopram (29/09/2006)
• Metoprolol Succinate SR (29/09/2006)
• Amlodypine (29/09/2006)
• Cefepim; Cefazolin (06/09/2006)
• China (29/06/2006)
• B hepatitis vaccine (09/03/2006)
• Octreotide (09/03/2006)
• Cefotiam (09/03/2006)
• Isepamicin (09/03/2006)